SCHEMBL2320538

SCHEMBL2320538

N#Cc1ccc(C2[CH]CC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
ALDH1A1 P00352 1/20 0.39
CYP2A6 P11509 1/20 0.39
CA12 O43570 1/20 0.39
CA2 P00918 1/20 0.39
CA3 P07451 1/20 0.39
CA6 P23280 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
CYP19A1 P11511 9/20 0.39
CYP11B1 P15538 3/20 0.37
CYP11B2 P19099 3/20 0.37
KCNH2 Q12809 1/20 0.37
TSHR P16473 1/20 0.37
HRH3 Q9Y5N1 1/20 0.36
KDM1A O60341 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2646076 0.86 CYP19A1 (0.41) MAOAMAOBALDH1A1CYP2A6CA12
SCHEMBL10814069 0.84 MAOA (0.43) MAOAMAOBCYP19A1CYP11B1CYP11B2
SCHEMBL28111674 0.82 CYP2A6 (0.42) MAOAMAOBALDH1A1CYP2A6CA12
SCHEMBL5958188 0.75 GRIA1 (0.49) MAOAMAOBALDH1A1CYP2A6CA12
SCHEMBL7734383 0.72 GRIA1 (0.41) MAOAMAOBALDH1A1CYP2A6CA12
SCHEMBL250894 0.71 MAOA (0.50) MAOAMAOBCYP19A1CYP11B1CYP11B2
SCHEMBL3706669 0.71 KCNH2 (0.46) MAOAMAOBALDH1A1CYP2A6CYP19A1
SCHEMBL23672525 0.70 KDM1A (0.43) KDM1A
SCHEMBL2324122 0.70 MEN1 (0.40) ALDH1A1CA3CA6CA14CYP19A1
SCHEMBL2872986 0.70 HTR3A (0.42) CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2356113-A1 HETEROCYCLICALLY SUBSTITUTED ARYL COMPOUNDS AS HIF INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2011-08-17 EP disclosed
WO-2010054763-A1 HETEROCYCLICALLY SUBSTITUTED ARYL COMPOUNDS AS HIF INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-05-20 WO disclosed